乐天堂app下载

Biography

Mike Waring is Chair of Medicinal Chemistry at Newcastle University and Head of Chemistry for 乐天堂app下载 Cancer Research UK Newcastle Drug Discovery Unit.  He was previously Principal Scientist in Medicinal Chemistry at AstraZeneca. He has worked mainly in 乐天堂app下载 areas of diabetes and oncology and his work has contributed to 乐天堂app下载 discovery of 14 drug candidates, including 乐天堂app下载 marketed EGFR inhibitor osimertinib (Tagrisso鈩�). 

He has made significant contributions to 乐天堂app下载 field in many areas, perhaps most notably property-based optimisation, covalent inhibition, novel binding modes and new methods of hit generation.  He is a 2018 American Chemical Society Hero of Chemistry and recipient of 乐天堂app下载 2017 RSC Malcolm Campbell Medal.  He is an elected fellow of 乐天堂app下载 Royal Society of Chemistry.

RSC affiliations

• Editor-in-Chief, RSC Medicinal Chemistry